| Stage | TOST | % of rev | ADP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.9B | 100.00% | $5.5B | 100.00% | ADP ×2.88 |
| Gross profit | $516M | 27.04% | $2.8B | 50.57% | ADP +23.5pp |
| Operating income | $152M | 7.97% | $1.5B | 26.64% | ADP +18.7pp |
| Pre-tax income | $162M | 8.49% | $1.5B | 26.50% | ADP +18.0pp |
| Net income | $154M | 8.07% | $1.1B | 20.49% | ADP +12.4pp |
| Stage | TOST | ADP | Gap · A − B |
|---|---|---|---|
| Revenue | $1.9B100.00% | $5.5B100.00% | ADP ×2.88 |
| Gross profit | 27.04%$516M | 50.57%$2.8B | ADP +23.5pp |
| Operating income | 7.97%$152M | 26.64%$1.5B | ADP +18.7pp |
| Pre-tax income | 8.49%$162M | 26.50%$1.5B | ADP +18.0pp |
| Net income |
| 8.07%$154M |
| 20.49%$1.1B |
| ADP +12.4pp |
No shared counterparties.